Friday - February 27, 2026
CRISPR-based platform pinpoints drivers of leukemia in patient cells
February 26, 2026
PHILADELPHIA, Pennsylvania, Feb. 26 -- The University of Pennsylvania's Perelman School of Medicine posted the following news:

* * *

CRISPR-based platform pinpoints drivers of leukemia in patient cells

*

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone marrow and blood. This first-of-its . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products